Surgery Partners's 15min chart signals MACD Death Cross, narrowing Bollinger Bands.

Surgery Partners' 15-minute chart has triggered a MACD Death Cross and Bollinger Bands Narrowing at 09/19/2025 14:30. This indicates a potential continuation of the downward trend in stock price, with a decreasing magnitude of price fluctuations.

Surgery Partners (NASDAQ:SGRY) has seen a significant shift in its technical indicators, with a MACD Death Cross and Bollinger Bands Narrowing observed on September 19, 2025, at 14:30. These indicators suggest a potential continuation of the downward trend in the stock price, accompanied by a decreasing magnitude of price fluctuations JPMorgan Chase & Co. Begins Coverage on Surgery Partners (NASDAQ:SGRY)^[1].

The MACD Death Cross, a bearish signal, occurs when the MACD line crosses below the signal line, indicating a potential trend reversal. Bollinger Bands Narrowing, on the other hand, indicates a reduction in volatility, which can often precede a significant price move, either up or down. In this case, the narrowing bands suggest a decrease in the price's magnitude of fluctuations, potentially signaling a continuation of the downward trend .

Surgery Partners reported strong quarterly earnings, with $826.20 million in revenue and $0.17 earnings per share, exceeding analyst expectations. Despite this, the technical indicators point to a potential slowdown in the stock's performance JPMorgan Chase & Co. Begins Coverage on Surgery Partners (NASDAQ:SGRY)^[1].

Analysts have responded to these indicators with varying opinions. JPMorgan Chase & Co. maintains a neutral rating with a price target of $27, indicating a potential upside of 23.91% from the current price. Bank of America, however, has initiated coverage with a "buy" rating and a $28.00 target price, while Barclays has set an "equal weight" rating with a target price of $24.00 JPMorgan Chase & Co. Begins Coverage on Surgery Partners (NASDAQ:SGRY)^[1].

Institutional investors have also shown interest in Surgery Partners, with several hedge funds increasing their positions in the stock. Deutsche Bank AG, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd., ProShare Advisors LLC, State of Wyoming, and Two Sigma Investments LP have all increased their holdings in the company JPMorgan Chase & Co. Begins Coverage on Surgery Partners (NASDAQ:SGRY)^[1].

While these technical indicators suggest a potential downward trend, investors should remain vigilant and consider the broader market conditions and the company's fundamentals before making investment decisions.